Biotech Stocks Blue Chip Stocks Healthcare Stocks Life Sciences

Why CSL’s US$11.7bn Bet On Vifor Has Failed, And If There Is Hope For The Future?

It is hard to look back on something and say it failed especially if it was a US$11.7bn bet as CSL's Vifor acquisition was. But what else can you say?…

ByNick Sundich

12

May 2026

Healthcare Stocks

CSL (ASX:CSL) Down 44% YTD at Decade Lows: Buying Opportunity or Falling Knife?

CSL Hits Decade Lows: Buy the Dip or Wait? CSL (ASX:CSL) shares slipped another 2% today, extending yesterday's brutal sell-off that pushed the stock to its lowest level since 2017.…

ByUjjwal Maheshwari

23

Apr 2026

Healthcare Stocks

ASX Healthcare Sector Sheds 6% in a Day: 3 Stocks Now Trading at Bargain Levels

The ASX healthcare sector lost 6% in a single day on Wednesday, its worst session in years. The trigger was Cochlear (ASX:COH), which fell 40.7% to a decade-low of A$99.58…

ByUjjwal Maheshwari

13

Apr 2026

Blue Chip Stocks Gold Stocks Healthcare Stocks Mining Stocks Small Caps Stocks Tech Stocks Technology Telecommunications Stocks Travel Stocks

Here Are 4 Stock Market Sectors With High Margins, And 4 With Low Margins!

Many investors may prefer stock market sectors with high margins over those with low margins. Profit margins are one of the simplest signals investors reach for when assessing business quality,…

ByNick Sundich

30

Mar 2026

Healthcare Stocks

The 4 Best ASX Healthcare Stocks to Buy as the Sector Trades at Two-Decade Valuation Lows

4 ASX Healthcare Stocks to Buy at Valuation Lows ASX healthcare stocks have had a brutal run. Five years of underperformance, persistent earnings downgrades, and aggressive rate hikes have pushed…

ByUjjwal Maheshwari

23

Feb 2026

Blue Chip Stocks

Here are 6 of the best results this ASX reporting season (so far), and 6 of the worst!

This article recaps some of the best results this ASX reporting season so far, as well as some of the worst - 6 of each to be exact. We are looking…

ByNick Sundich

16

Feb 2026

Biotech Stocks Blue Chip Stocks Consumer

Here are some ASX stocks that will benefit from a higher AUD, and stocks that will lose

The Aussie dollar has been surging in recent weeks and there are ASX stocks that will benefit from a higher AUD - as well as some that will lose. We…

ByNick Sundich

14

Feb 2026

Healthcare Stocks

Why ASX Healthcare Stocks Are Crashing- and Which One Looks Like a Buy

ASX healthcare stocks are crashing- which one is worth buying now? Three of Australia's most premium ASX healthcare stocks have been crushed in the same week. CSL (ASX: CSL) has…

ByUjjwal Maheshwari

11

Feb 2026

Biotech Stocks Healthcare Stocks Life Sciences

CSL CEO Paul McKenzie has departed, now what for the fallen biotech giant?

In a bombshell 4pm announcement, investors learned that CSL CEO Paul McKenzie was departing the company effective that very afternoon following a tenure of nearly 3 years. It was clear…

ByNick Sundich

28

Oct 2025

Blue Chip Stocks Market news

CSL Cuts FY26 Guidance And Plunges 20% (What Investors Need to Know)

CSL Cuts FY26 Guidance, Shattering Investor Confidence CSL surprised investors today as its share price dropped around 20% following its latest market update, delivered on the same day at its…

ByCharlie Youlden

Why CSL’s US$11.7bn Bet On Vifor Has Failed, And If There Is Hope For The Future?

CSL (ASX:CSL) Down 44% YTD at Decade Lows: Buying Opportunity or Falling Knife?

ASX Healthcare Sector Sheds 6% in a Day: 3 Stocks Now Trading at Bargain Levels

Here Are 4 Stock Market Sectors With High Margins, And 4 With Low Margins!

The 4 Best ASX Healthcare Stocks to Buy as the Sector Trades at Two-Decade Valuation Lows

Here are 6 of the best results this ASX reporting season (so far), and 6 of the worst!

Here are some ASX stocks that will benefit from a higher AUD, and stocks that will lose

Why ASX Healthcare Stocks Are Crashing- and Which One Looks Like a Buy

CSL CEO Paul McKenzie has departed, now what for the fallen biotech giant?

CSL Cuts FY26 Guidance And Plunges 20% (What Investors Need to Know)

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Stocks in Spotlight

Add Your Heading Text Here